Your browser doesn't support javascript.
loading
Optimized production and fluorescent labelling of SARS-CoV-2 Virus-Like-Particles to study virus assembly and entry.
Delphine Muriaux; Manon Gourdelier; Jitendriya M Swain; Coline Arone; Anita Mouttou; David Bracquemond; Peggy Merida; Saveez Saffarian; Sebastien Lyonnais; Cyril Favard.
Afiliação
  • Delphine Muriaux; CNRS & University of Montpellier
  • Manon Gourdelier; CNRS & University of Montpellier
  • Jitendriya M Swain; CNRS & University of Montpellier
  • Coline Arone; CNRS & University of Montpellier
  • Anita Mouttou; CNRS & University of Montpellier
  • David Bracquemond; CNRS & University of Montpellier
  • Peggy Merida; CNRS
  • Saveez Saffarian; University of Utah
  • Sebastien Lyonnais; CNRS
  • Cyril Favard; CNRS & University of Montpellier
Preprint em Inglês | bioRxiv | ID: ppbiorxiv-485575
ABSTRACT
SARS-CoV-2 is an RNA enveloped virus responsible for the COVID-19 pandemia that conducted in 6 million deaths worldwide so far. SARS-CoV-2 particles are mainly composed of the 4 main structural proteins M, N, E and S to form 100nm diameter viral particles. Based on productive assays, we propose an optimal transfected plasmid ratio mimicking the virus RNA ratio allowing SARS-CoV-2 Virus-Like Particle (VLPs) formation composed of the viral structural proteins M, N, E and S. Furthermore, monochrome, dual-color fluorescent or photoconvertible VLPs were produced. Thanks to live fluorescence and super-resolution microscopy, we quantified VLPs size and concentration. It shows a diameter of 110 and 140 nm respectively for MNE-VLPs and MNES-VLPs with a minimum concentration of 10e12 VLP/ml. SARS-CoV-2 VLPs could tolerate the integration of fluorescent N and M tagged proteins without impairing particle assembly. In this condition, we were able to establish incorporation of the mature Spike in fluorescent VLPs. The Spike functionality was then shown by monitoring fluorescent MNES-VLPs docking and endocytosis in human pulmonary cells expressing the receptor hACE2. This work provides new insights on the use of non-fluorescent and fluorescent VLPs to study and visualize the SARS-CoV-2 viral life cycle in a safe environment (BSL-2 instead of BSL-3). Moreover, optimized SARS-CoV-2 VLP production can be further adapted to vaccine design strategies.
Licença
cc_no
Texto completo: Disponível Coleções: Preprints Base de dados: bioRxiv Idioma: Inglês Ano de publicação: 2022 Tipo de documento: Preprint
Texto completo: Disponível Coleções: Preprints Base de dados: bioRxiv Idioma: Inglês Ano de publicação: 2022 Tipo de documento: Preprint
...